跳至主要内容
临床试验/EUCTR2015-002212-32-DE
EUCTR2015-002212-32-DE进行中(未招募)1 期

Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: Amulticentre randomized Trial

niversität Leipzig0 个研究点目标入组 292 人开始时间: 2015年10月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
292

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Acute-on-chronic liver failure (ACLF) according to the consensus criteria recently defined by the CANONIC study group [Moreau 2013]. Patients with acute decompensation of cirrhosis [defined as acute development of one or more of the following: ascites (onset and/or worsening), hepatic encephalopathy (onset and/or worsening), gastrointestinal haemorrhage, bacterial infection] are classified as ACLF if one of the following applies:
  • single kidney failure (serum creatinine level = 2 mg/dl) or
  • single failure of one of the following organ systems: liver, coagulation, circulation, or respiration,
  • together with
  • a serum creatinine level ranging from 1.5 to < 2.0 mg/dl and/or mild to moderate hepatic encephalopathy or
  • single cerebral failure together with serum creatinine level ranging from 1.5 to < 2.0 mg/dl or
  • two or more organ failures.
  • Organ failures are defined according to the CLIF-C OFs [Jalan 2014].
  • 2.Age = 18 years, male or female
  • 3.Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 250
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 42

排除标准

  • 1.Prior not curatively treated or active malignancies
  • 2.Sickle cell disease
  • 3.Septic shock, defined by the following symptom complex: bacteraemia AND SIRS AND shock
  • 4.WBC-count of > 50 x 109/L
  • 5.Known HIV infection
  • 6.Known intolerance to filgrastim
  • 7.Suspected lack of compliance
  • 8.Pregnant or nursing women
  • 9.Fertile women (within two years of their last menstruation) without appropriate contraceptive measures (implanon, injections, oral contraceptives, intrauterine devices, partner with vasectomy) while participating in the trial (participants using a hormone-based method have to be informed of possible effects from the trial medication on contraception).
  • 10.Participation in other interventional trials

研究者

发起方
niversität Leipzig

相似试验